65.31 USD
↗ 0.45 (0.69%)AT CLOSE (11:59 AM EDT)
Bristol-Myers Squibb Co.
BMYNYSE • USD
65.40
↗ 0.09 (0.13%)
POST MARKET (AS OF 08:13 PM EDT)
Post Market
AS OF 08:13 PM EDT
65.40
↗ 0.09 (0.13%)
Market: CLOSED
Bristol-Myers Squibb Co. (BMY) trades at $65.31 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include exceptional Return on Equity (41.6%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, BMY appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 31, 2026.
Open?$65.00
High?$65.66
Low?$63.53
Prev. Close?$64.86
Volume?14.6M
Avg. Volume?12.8M
VWAP?$64.73
Rel. Volume?1.14x
Bid / Ask
Bid?$65.34 × 200
Ask?$65.40 × 200
Spread?$0.06
Midpoint?$65.37
Valuation & Ratios
Market Cap?133.4B
Shares Out?2.0B
Float?2.0B
Float %?99.9%
P/E Ratio?14.37
P/B Ratio?5.98
EPS?$4.54
Dividend?3.82%
Ex-Dividend?N/A
News
Profile
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Themes
Address
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
Phone: (609) 252-4621
PRINCETON, NJ 08543
Phone: (609) 252-4621
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?61
Momentum?77
Short Sent.?52
Piotroski F-Score?5/9Mixed
Altman Z-Score?2.69Grey
Confidence?79%Moderate
Short InterestModerate
Short % of Float?2.20%Low
Short Interest?44.9M
Days to Cover?4.2
Free Float2.0B
Avg Daily Volume10.6M
Settlement Date2026-07-15
Financial Health
Current Ratio?1.53Adequate
Quick Ratio?1.38Adequate
Cash Ratio?0.47Low
Debt/Equity?1.93High
ValuationATTRACTIVELY VALUEDvs 10 peers + S&P 500
Score89/100
P/E?14.4CHEAP▾
Peers100
S&P83
P/B?5.98FAIR▾
Peers90
S&P31
P/S?2.71CHEAP▾
Peers91
S&P54
P/FCF?11.7CHEAP▾
Peers100
S&P84
EV/EBITDA?11.3CHEAP▾
Peers91
S&P73
EV/Sales?3.41FAIR▾
Peers91
S&P55
Returns & Efficiency
ROE?41.6%STRONG▾
Peers70
S&P89
ROA?10.6%STRONG▾
Peers64
S&P76
Cash Flow & Enterprise
FCF?$11.4B
Enterprise Value?$167.8B
Fundamentals ratios updated end of day